CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-15 | GEMAYEL GEORGES Director | Grant or award · Stock Option (Right to Buy) | +23,514 | 23,514 | ||
| 2021-11-15 | GEMAYEL GEORGES Director | Grant or award · Stock Option (Right to Buy) | +17,245 | 17,245 | ||
| 2021-10-18 | Piekos Brian Chief Financial Officer | Grant or award · Restricted Stock Units | +90,720 | 90,720 | ||
| 2021-10-04 | Ong Tuyen Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2021-10-04 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +0 | 0 | ||
| 2021-10-04 | Tananbaum James B. Director | Grant or award · Stock Option (Right to Buy) | +17,245 | 17,245 | ||
| 2021-10-04 | Rhodes Jason P Director | Grant or award · Stock Option (Right to Buy) | +17,245 | 17,245 | ||
| 2021-10-04 | GORDON CARL L Director | Grant or award · Stock Option (Right to Buy) | +17,245 | 17,245 | ||
| 2021-10-04 | Ong Tuyen Director | Grant or award · Stock Option (Right to Buy) | +17,245 | 17,245 | ||
| 2021-10-04 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +17,245 | 17,245 | ||
| 2021-05-14 | Piekos Brian Chief Financial Officer | Purchase | +7,655 | $9.46 | $72K | 7,655 |
| 2021-05-14 | Meyenburg Jason Patrick President & CEO | Purchase | +13,000 | $9.46 | $123K | 13,000 |
| 2021-04-29 | GEMAYEL GEORGES Director | Grant or award · Stock Option (Right to Buy) | +45,466 | 45,466 | ||
| 2021-04-29 | Strapps Walter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2021-04-12 | Piekos Brian Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +377,734 | 377,734 | ||
| 2021-04-12 | Barone Samuel B. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +255,212 | 255,212 | ||
| 2021-03-12 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +17,529 | 17,529 | ||
| 2021-03-12 | Ong Tuyen Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-03-12 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-03-01 | Strapps Walter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +99,133 | 99,133 |
Page 33 of 34 · 676 trades